Search
Search Results
##search.searchResults.foundPlural##
-
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1912Suppl. Files: 893HTML: 436PDF: 756 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3067PDF: 918HTML: 2042 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6363PDF: 2138HTML: 14027Untitled: 206figure: 189 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1983PDF: 827HTML: 2206Table 1: 182Table 2: 202Table 3: 196Table 4: 201Table 5: 197Tble 6: 189Cover Letter: 210Greene Tab.7: 199 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4294PDF: 1533HTML: 459 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4006Suppl. Files: 1140PDF: 1087Html: 180 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2093PDF: 1904HTML: 350 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1870PDF: 729HTML: 2118Untitled: 224Untitled: 157Untitled: 176Untitled: 160Untitled: 169Untitled: 183Untitled: 190 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1737PDF: 1109HTML: 10704Untitled: 194 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4837PDF: 1795HTML: 2723Untitled: 227 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2296PDF: 1641HTML: 276 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3773PDF: 1595HTML: 8050Randi Fig: 187 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4154PDF: 1974HTML: 1774 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4018PDF: 1057HTML: 3603Untitled: 178Cneo. Fig.1: 115Untitled: 108Untitled: 129Untitled: 135 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4376PDF: 1723HTML: 1043 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3642PDF: 1661HTML: 2679 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2148PDF: 1005HTML: 4079Cover Letter: 225Figure 1: 237Figure 2: 235Table 1: 207 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5361PDF: 2771HTML: 30227Antinori Tables 1,2,3: 357 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2436PDF: 1598HTML: 647 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1422PDF: 492HTML: 3976 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3602PDF: 1513HTML: 4420CoverLetter: 188Figure1: 200 -
-
IMMUNOLOGY OF TUBERCULOSIS
5369PDF: 2019HTML: 7339Untitled: 196 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6143PDF: 3332HTML: 9029Figure Malaria Ricci: 232 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2499PDF: 1322HTML: 1791CoverLetter: 185 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2259PDF: 972HTML: 5071Cover Letter: 172Figure 2: 166Figure 1: 177Figure 3: 199Figure 4: 172Figure Legend: 190Table 1: 193Table 2: 186Table 3: 185 -
-
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8050PDF: 4246HTML: 7510 -
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
567PDF: 303Html: 25 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3581PDF: 2510HTML: 1497 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4793PDF: 1568HTML: 2251Untitled: 217Untitled: 233Untitled: 237Untitled: 223Untitled: 224 -
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major
638PDF: 522Html: 109 -
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
90PDF: 69HTML: 12 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2402PDF: 1415HTML: 1991







